Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase
- PMID: 15149770
- DOI: 10.1016/j.vaccine.2003.12.004
Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase
Abstract
As measured by fluid accumulation in ileal loops, Vibrio cholerae mucinase complex, with or without toxoid, protected guinea pigs from challenges with V. cholerae live organisms and enterotoxin. The neuraminidase and proteinases of the complex were combined in modified oil emulsion or aluminum hydroxide adjuvants and the resultant vaccines given by the parenteral or oral routes. There was little difference between the two types of adjuvant. Control of stomach acidity improved oral vaccination. Animals injected intramuscularly (i.m.) with toxoid-containing vaccines were protected from challenge with cholera toxin (CT) whereas those given oral doses were not. Toxoid plus killed V. cholerae cells elicited a more effective protection against toxin challenge than killed V. cholerae cells alone. Vaccines containing mucinases, with or without toxoid, protected the animals from a live V. cholerae challenge. The anti-mucinase immune response may prevent adhesion of the V. cholerae cells and hence reduce delivery of toxin to receptors. These mucinases, neuraminidase and proteinases, may be useful components of acellular, toxoided cholera vaccines for human immunisation.
Similar articles
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.FEMS Immunol Med Microbiol. 2009 Jul;56(2):179-84. doi: 10.1111/j.1574-695X.2009.00563.x. Epub 2009 May 5. FEMS Immunol Med Microbiol. 2009. PMID: 19453752
-
Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.Dev Biol Stand. 1983;53:67-72. Dev Biol Stand. 1983. PMID: 6873478
-
Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.Dev Biol Stand. 1983;53:59-65. Dev Biol Stand. 1983. PMID: 6873477
-
[Cholera immunology and the molecular biology of cholera toxin. Recent progress and future prospects].Rev Alerg. 1993 Jul-Aug;40(4):91-4. Rev Alerg. 1993. PMID: 8143024 Review. Spanish.
Cited by
-
Immunization with cholera toxin B subunit induces high-level protection in the suckling mouse model of cholera.PLoS One. 2013;8(2):e57269. doi: 10.1371/journal.pone.0057269. Epub 2013 Feb 28. PLoS One. 2013. PMID: 23468950 Free PMC article.
-
Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.Clin Vaccine Immunol. 2014 Sep;21(9):1195-205. doi: 10.1128/CVI.00378-14. Epub 2014 Jul 23. Clin Vaccine Immunol. 2014. PMID: 25056361 Free PMC article. Review.
-
Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days.BMC Immunol. 2020 May 25;21(1):29. doi: 10.1186/s12865-020-00360-1. BMC Immunol. 2020. PMID: 32450807 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials